Cytokine Release Syndrome Resulting From Anti–Programmed Death-1 Antibody: Raising Awareness Among Community Oncologists

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Leena Gandhi, Delvys Rodríguez‐Abreu, Shirish M. Gadgeel et al. · New England Journal of Medicine · 2018 · 6.4K citations · Full text

Current concepts in the diagnosis and management of cytokine release syndrome

Daniel W. Lee, Rebecca Gardner, David Porter et al. · Blood · 2014 · 2.7K citations

Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412

Ganesh Suntharalingam, Meghan Perry, Stephen Ward et al. · New England Journal of Medicine · 2006 · 2.1K citations

Immunology, Immunologic Mechanism, Cd4 T Cell Responses +20

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome

Robert Q. Le, Liang Li, Weishi Yuan et al. · The Oncologist · 2018 · 859 citations · Full text

Severe cytokine release syndrome in a patient receiving PD‐1‐directed therapy

Seth J. Rotz, Daniel Leino, Sara Szabo et al. · Pediatric Blood & Cancer · 2017 · 154 citations

Immunology, Pathology, Immune System +20